Tweenvest Stocks

Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHSE: 603207)

Health Care · Pharmaceuticals · CN

CN¥24.47

+0.04% today · -26.3% 1Y

Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHSE: 603207) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $586.98M.

Over the last twelve months the share price has lost 26.3%, trading between 21.31 and 34.05.

Tweenvest scores Shanghai Xiao Fang Pharmaceutical Co.,Ltd. across four factors: quality 92/100, value 47/100, growth 38/100, dividend 68/100. Its strongest factor is quality.

603207 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$586.98M
Revenue (TTM)
$79.12M
P/E
20.40
EPS
1.20
Dividend yield
4.37%
Beta (5Y)
-0.01
52-week high
CN¥34.05
52-week low
CN¥21.31
Avg volume (3M)
—
Shares outstanding
160.67M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
ChengDu ShengNuo Biotec Co.,Ltd.SHSE: 688117$593.11MCN¥18.03-2.86%
Tibet Weixinkang Medicine Co., Ltd.SHSE: 603676$592.53MCN¥9.18+0.99%
Middle East Pharmaceutical Industries CompanySASE: 4016$589.61MSR63.25+1.69%
Hefei Lifeon Pharmaceutical Co., Ltd.SZSE: 003020$589.45MCN¥17.30+0.23%
Huaren Pharmaceutical Co., Ltd.SZSE: 300110$584.21MCN¥3.31+4.42%
Qianjiang Yongan Pharmaceutical Co., Ltd.SZSE: 002365$581.48MCN¥13.47-0.07%
Zhejiang Yatai Pharmaceutical Co., Ltd.SZSE: 002370$580.00MCN¥5.21+0.97%
Phathom Pharmaceuticals, Inc.NasdaqGS: PHAT$575.87M$7.25+4.77%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.